23andMe Holding Co.
NASDAQ: ME0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Select
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Joseph Selsavage
- Employees
- 560
- Headquarters
- South San Francisco, United States
- IPO year
- 2020
- Market cap
- $15.3M
- Website
- https://www.23andme.com
Loading ME…
Loading profile data…Frequently asked questions about ME
What does 23andMe Holding Co. (ME) do?
23andMe Holding Co. is a prominent direct-to-consumer genetic testing firm, structured around two primary business units: Consumer & Research Services and Therapeutics. Through its Consumer & Research Services division, the company provides individuals with a comprehensive suite of genetic reports, derived from a simple saliva sample collected v...
Where does ME trade?
23andMe Holding Co. (ME) trades on the NASDAQ Global Select.
What sector is ME in?
23andMe Holding Co. (ME) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of 23andMe Holding Co.?
Joseph Selsavage is the chief executive officer of 23andMe Holding Co. (ME).
Where is 23andMe Holding Co. headquartered?
23andMe Holding Co. is headquartered in United States.
Does ME pay a dividend?
23andMe Holding Co. (ME) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ME go public?
23andMe Holding Co. (ME) completed its initial public offering in 2020.